Source: iQoncept / Shutterstock
Talis Biomedical (NASDAQ:TLIS) just reported results for the fourth quarter of 2023.
- Talis Biomedical reported earnings per share of -$7.39.
- The company reported revenue of $195,000.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/03/tlis-stock-earnings-talis-biomedical-for-q4-of-2023/.
©2024 InvestorPlace Media, LLC

